Bordeaux, Boston, 5 April 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that it has been granted 510k clearance in the United States and the CE mark in Europe to market its new Jazz Lock® implant. Jazz Lock® is the first of an […]